Bioceltix Balance Sheet Health
Financial Health criteria checks 6/6
Bioceltix has a total shareholder equity of PLN41.4M and total debt of PLN0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are PLN44.4M and PLN3.0M respectively.
Key information
0%
Debt to equity ratio
zł0
Debt
| Interest coverage ratio | n/a |
| Cash | zł38.20m |
| Equity | zł41.43m |
| Total liabilities | zł2.96m |
| Total assets | zł44.39m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: XI3's short term assets (PLN41.7M) exceed its short term liabilities (PLN2.7M).
Long Term Liabilities: XI3's short term assets (PLN41.7M) exceed its long term liabilities (PLN271.1K).
Debt to Equity History and Analysis
Debt Level: XI3 is debt free.
Reducing Debt: XI3 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: XI3 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: XI3 has sufficient cash runway for 1.6 years if free cash flow continues to reduce at historical rates of 46.5% each year.